Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 16/20 | 0.40 |
| ▸ | TACR2 | P21452 | 1/20 | 0.37 |
| ▸ | TACR3 | P29371 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6962396 | 0.80 | TACR1 (0.38) | TACR1TACR2 | |
| SCHEMBL6962536 | 0.73 | TACR1 (0.48) | TACR1TACR2TACR3 | |
| SCHEMBL6966843 | 0.70 | TACR1 (0.48) | TACR1TACR2TACR3 | |
| SCHEMBL4630843 | 0.70 | TACR1 (0.47) | TACR1TACR2TACR3 | |
| SCHEMBL6956698 | 0.65 | TACR1 (0.40) | TACR1TACR2 | |
| SCHEMBL7819383 | 0.65 | TACR1 (0.62) | TACR1TACR2TACR3 | |
| SCHEMBL4631258 | 0.65 | TACR1 (0.47) | TACR1TACR2TACR3 | |
| SCHEMBL7956540 | 0.65 | CCR5 (0.58) | TACR1TACR2TACR3 | |
| SCHEMBL8559263 | 0.64 | TACR1 (0.64) | TACR1TACR2TACR3 | |
| SCHEMBL4631239 | 0.64 | TACR1 (0.44) | TACR1TACR2TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0790248-B1 | 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists | PFIZER LTD (GB) | 2003-05-28 | — | — | EP | disclosed |
| US-5846965-A | 3-aza and 3-oxa piperidone tachykinin antagonists | PFIZER INC. (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0790248-A1 | 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists | Pfizer Limited (GB) | 1997-08-20 | — | — | EP | disclosed |